International collaboration makes it easier for patients travelling from Denmark to access specialist MRI scans as part of their Alzheimer’s treatment journey.
Re:Cognition Health has established a collaboration with Danish diagnostic imaging clinic Progardia, enabling patients travelling from Denmark to the UK for Alzheimer’s treatment to access specialist MRI scans closer to home.
The partnership aims to make treatment journeys more convenient for patients and their families, reducing the need for additional travel to London while ensuring access to the high-quality imaging required to support clinical assessment, treatment planning and ongoing safety monitoring.
Why MRI monitoring is important in Alzheimer’s treatment
MRI scans play an essential role in the assessment and monitoring of patients receiving disease-modifying Alzheimer’s treatments.
The new-generation Alzheimer’s treatments, such as Kisunla and Leqembi, target amyloid plaques in the brain, one of the biological hallmarks of Alzheimer’s disease. However, these treatments can be associated with a potential side effect known as amyloid-related imaging abnormalities (ARIA). These can involve swelling or bleeding in the brain and, in some cases, may occur without noticeable symptoms.
Regular MRI monitoring is therefore an important part of treatment safety protocols, allowing clinicians to identify potential abnormalities and make informed decisions about continuing or adjusting treatment where necessary.
For patients travelling internationally to receive treatment, coordinating these scans can present additional logistical challenges. The collaboration between Re:Cognition Health and Progardia helps address this by enabling patients to undergo the required imaging in Denmark, with the results securely transferred to the clinical team in London for review.
Advanced imaging and a specialist-approved protocol
Re:Cognition Health worked closely with Progardia to establish a dedicated MRI protocol, with test images reviewed and approved by the clinic’s specialists to ensure scans meet the required standards for clinical assessment.
Progardia uses a 3 Tesla MRI scanner, which produces detailed images of the brain. Equipped with the latest AI-powered imaging technology, the scanner delivers exceptional image quality to support accurate clinical assessment and decision-making.
Its neuroradiology specialists review the images and prepare reports in both Danish and English, which are securely shared with Re:Cognition Health.
This coordinated approach allows the clinical team in the UK to incorporate the imaging into their assessment and treatment decisions, supporting continuity of care across both countries.
Putting patients and families first
For patients travelling from Denmark, being able to access specialist imaging locally can make a meaningful difference to the experience of receiving treatment abroad.
Previously, patients could need to travel to London several days before treatment to undergo the necessary MRI scans. Through the collaboration, these examinations can now take place at Progardia, located in Middlefart, Denmark, reducing additional travel, associated costs and the practical demands placed on patients and their families.
Progardia also places considerable emphasis on patient comfort, offering a welcoming MRI environment where patients can watch films through a dedicated mirror system inside the scanner, helping to make the experience more comfortable and reassuring.
The collaboration also provides flexibility when additional imaging is required. Where clinically indicated, patients can arrange further MRI examinations in Denmark to support the assessment of potential side effects and ongoing safety monitoring between treatments.
Dustin Reibe, Operations Director at Re:Cognition Health, explains:
“At Re:Cognition Health, we recognise that travelling internationally for specialist treatment can place additional demands on patients and their families. Being able to access important MRI scans closer to home helps reduce that burden, without compromising the quality of imaging or the clinical oversight required throughout treatment.
“Our collaboration with Progardia makes this possible for patients travelling from Denmark to the UK. Its advanced 3 Tesla MRI technology, specialist imaging expertise and flexible appointment scheduling allow scans to be coordinated around individual treatment plans and follow-up requirements.
“Just as importantly, it gives patients the opportunity to undergo additional imaging in Denmark when clinically required, supporting the safety monitoring that is such an important part of disease-modifying Alzheimer’s treatment.
“Ultimately, this partnership reflects our commitment to putting patients first. We want to make specialist care as accessible and convenient as possible, while ensuring patients receive the appropriate clinical assessment, monitoring and support throughout their treatment journey.”
A more connected approach to international Alzheimer’s care
The collaboration with Re:Cognition Health and Progardia reflects commitment to developing international partnerships that improve the patient experience and support access to specialist Alzheimer’s care.
As disease-modifying treatments become an increasingly important part of the Alzheimer’s treatment landscape, the infrastructure surrounding them is equally important. This includes access to appropriate diagnostic imaging, timely clinical assessments and ongoing monitoring.
By bringing together Re:Cognition Health’s expertise in neurological assessment and Alzheimer’s treatment with Progardia’s advanced imaging capabilities, the partnership offers Danish patients a more streamlined approach to receiving specialist care in the UK.
It is another example of how international collaboration can help remove practical barriers to treatment, making it easier for patients and their families to navigate what can be a complex and demanding journey.
Find out more about Progardia’s patient-friendly MRI environment, MRI technology and quality standards, and its collaboration with Re:Cognition Health.
Danish patients can also read more about MRI scanning for Alzheimer’s disease.
For consultations at Re:Cognition Health and to find out more about new treatments to slow Alzheimer’s visit: https://www.recognitionhealth.com/alzheimersmedication/
Or call 0800 802 1030
